Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20398925 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
Conditions: Prostate Cancer;   Hormone Refractory Prostate Cancer
Intervention: Drug: MDV3100

Indicates status has not been verified in more than two years